SCPH
Price:
$5.67
Market Cap:
$302.20M
scPharmaceuticals Inc. is a pharmaceutical firm dedicated to developing and commercializing a variety of medicinal products. Its primary investigational therapy, FUROSCIX, is a specialized formulation of furosemide delivered through an on-body infusor, intended for managing congestion in heart failure patients. The company's pipeline also encompasses scCeftriaxone, an antibiotic aimed at treating infections caused by both gram-positive and gram-negative bacteria, as well as the scCarbapenem program, another antibiotic designed for gram-negative bacterial infections. Additionally, scPharmaceuticals has entered into a collaboration agreement with West Pharmaceutical Services, Inc. for the adva...[Read more]
Industry
Biotechnology
IPO Date
2017-11-17
Stock Exchange
NASDAQ
Ticker
SCPH
According to scPharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.13. This represents a change of 52.27% compared to the average of -2.06 of the last 4 quarters.
The mean historical PE Ratio of scPharmaceuticals Inc. over the last ten years is -4.91. The current -3.13 PE Ratio has changed 6.28% with respect to the historical average. Over the past ten years (40 quarters), SCPH's PE Ratio was at its highest in in the September 2016 quarter at -0.41. The PE Ratio was at its lowest in in the September 2017 quarter at -11.31.
Average
-4.91
Median
-4.22
Minimum
-15.02
Maximum
-1.50
Discovering the peaks and valleys of scPharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 57.56%
Maximum Annual PE Ratio = -1.50
Minimum Annual Increase = -76.79%
Minimum Annual PE Ratio = -15.02
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -1.85 | -57.99% |
| 2023 | -4.41 | -20.18% |
| 2022 | -5.52 | 12.69% |
| 2021 | -4.90 | 21.38% |
| 2020 | -4.04 | 31.91% |
| 2019 | -3.06 | 29.09% |
| 2018 | -2.37 | 57.56% |
| 2017 | -1.50 | -76.79% |
| 2016 | -6.48 | -56.85% |
The current PE Ratio of scPharmaceuticals Inc. (SCPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.93
5-year avg
-4.14
10-year avg
-4.91
scPharmaceuticals Inc.’s PE Ratio is greater than Climb Bio, Inc. (-14.78), greater than Inozyme Pharma, Inc. (-4.67), less than Checkpoint Therapeutics, Inc. (-0.06), greater than Third Harmonic Bio, Inc. (-8.35), greater than Vigil Neuroscience, Inc. (-5.26), greater than Orchard Therapeutics plc (-27.11), less than Spectrum Pharmaceuticals, Inc. (-2.40), greater than Standard BioTools Inc. (-3.66), greater than 2seventy bio, Inc. (-13.93), less than Acelyrin, Inc. (-1.70),
| Company | PE Ratio | Market cap |
|---|---|---|
| -14.78 | $780.03M | |
| -4.67 | $258.25M | |
| -0.06 | $367.72M | |
| -8.35 | $242.79M | |
| -5.26 | $375.71M | |
| -27.11 | $380.11M | |
| -2.40 | $210.38M | |
| -3.66 | $346.53M | |
| -13.93 | $266.14M | |
| -1.70 | $229.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like scPharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like scPharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is scPharmaceuticals Inc.'s PE Ratio?
How is the PE Ratio calculated for scPharmaceuticals Inc. (SCPH)?
What is the highest PE Ratio for scPharmaceuticals Inc. (SCPH)?
What is the 3-year average PE Ratio for scPharmaceuticals Inc. (SCPH)?
What is the 5-year average PE Ratio for scPharmaceuticals Inc. (SCPH)?
How does the current PE Ratio for scPharmaceuticals Inc. (SCPH) compare to its historical average?